Diversity in clinical trials is lacking, according to Chris Boone, vice president, Global Head of Health Economics and Outcomes Research at Abbvie, a pharmaceutical and research development company.
Less than 16% people of color are in clinical trials, when 39% of the U.S. population is made up of people of color. An estimated 1% of Hispanic Americans are represented in clinical trials and they are 16% of the population.
